Evidence map›Paper›PMID 40999433›Full record

ArticleBMC public health2025

Association between statin use and the risk of atrial fibrillation in community-dwelling older people in Shanghai, China: a propensity score-matched study.

Tiantian Deng, Fei Sheng, Ziqiang Zhang

Abstract read
In one paragraph

Article in BMC public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Tiantian DengNanxiang Town Community Health Center, School of Medicine, Tongji University, Shanghai, China.
Fei ShengNanxiang Town Community Health Center, School of Medicine, Tongji University, Shanghai, China.
Ziqiang ZhangDepartment of Respiratory and Critical Care Medicine, Shanghai Pudong Hospital, Fudan University Pudong Medical Center, Pudong Hospital of Fudan University, 2800 Gongwei Road, Shanghai, 201399, China. zzq1419@126.com.

Funding

Natural Science Research Project of Shanghai Jiading District NO. JDKW-2024-0041Scientific Research Foundation of Shanghai Pudong Hospital for Advanced Talents and Key Discipline Projects of Shanghai Pudong Hospital No. YJYJRC202303, LJ202402 and No.02 Zdxk2020-08
6 · The paper itself

Abstract

objectiveWhether statins, as upstream therapy for atrial fibrillation (AF), can reduce the incidence of AF in elderly individuals remains unclear. This study aimed to examine whether statin use is linked to a lower risk of incident AF in older adults from Shanghai, China. To provide important implications for optimizing the prevention and management strategies of AF in the elderly.

methodsData for this retrospective cohort study were collected from a community health service center in Shanghai. Individuals had no history of AF in 2018 and before were included, and new cases of AF were documented in 2019, 2020, and 2021. A Poisson generalized linear model was used to evaluate the relationship between statin treatment and AF incidence. Both standard covariate adjustment and propensity score matching (PSM) to control for confounding factors. To evaluate the risk factors for new-onset AF among the elderly, univariate logistic analysis was conducted. Variables with statistical significance in univariate analysis (p < 0.05), such as sex, age, SBP, BMI, WHR, Scr and HbA1c were selected as covariates for inclusion in the multivariable logistic regression model.

resultsOut of the 5675 individuals in the study group (43.5% male; median age of 68 years), 456 participants (8.0%) received statin treatment. The propensity score unmatched and matched cohorts of 453 participants (stain users and nou-users) were evaluated, in each group. There was no reduction in AF incidence with statin use (95%CI, 0.948 to 1.018) in the unmatched cohort and in the matched cohort (95%CI, 0.459 to 1.512). The multivariate regression analysis results showed that age, SBP, BMI, HbA1c and Scr were factors independently linked to the occurrence of new-onset AF. Despite extensive analysis, our study did not find evidence that statin use reduces the risk of new-onset AF in this population.

conclusionFor older people, taking statins did not reduce risk of new on-set AF. Independent predictors of AF onset including age, SBP, BMI, HbA1c and Scr. This is a retrospective cohort study, making it difficult to completely control for all confounding factors, and the short follow-up period may have resulted in insufficient statistical power to detect a meaningful effect of statins on atrial fibrillation. Future studies may use randomized controlled studies to explore the effects of different types and doses of statins on new-onset atrial fibrillation in older adults.

Indexed as

Atrial FibrillationHydroxymethylglutaryl-CoA Reductase InhibitorsIndependent LivingAgedAged, 80 and overChinaFemaleHumansIncidenceMaleMiddle AgedPropensity ScoreRetrospective StudiesRisk FactorsHydroxymethylglutaryl-CoA Reductase InhibitorsAtrial fibrillationCommunity-dwelling older peopleStatins

Identifiers

PMID40999433
PMCPMC12465881

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.